
To develop SXRNSCLC-PRSP software which can predict the prognostic risk and survival of resected TNM (according to the 9th AJCC/UICC TNM stage of lung cancer) non-small cell lung cancer (NSCLC) patients in Shanxi Province China more comprehensively, accurately and conveniently, and provide reference...

Although tyrosine kinase inhibitors (TKIs) significantly improve survival outcomes in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), tumor clonal evolution under drug pressure inevitably leads to acquired resistance. DNA damage response (DDR) mutations...

Non-small cell lung cancer (NSCLC) poses a major threat to human health due to its high morbidity and mortality. Early accurate diagnosis and differential diagnosis from other respiratory diseases, are pivotal to improving patient prognosis. This study aimed to construct an NSCLC diagnostic model based...

This study aims to provide a comprehensive bibliometric evaluation of the most influential publications on salvage surgery for non-small cell lung cancer from 1991 to 2023, highlighting scientific trends, geographic contributions, journal impact, and major clinical themes. A systematic search was conducted...